What benefit do patients expect from adding second and third antihypertensive drugs?

British Journal of Clinical Pharmacology

Volumn 53, Issue 1, 2002, Pages 93-99

  Leaman, Hannah ^a   Jackson, Peter R ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Hypertension; Multiple drugs; Patients' views

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; EDUCATION; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; MALE; MEDICAL DECISION MAKING; PATIENT ATTITUDE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK BENEFIT ANALYSIS; SEX DIFFERENCE; TREATMENT OUTCOME;

EID: 0036164841     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0306-5251.2001.01505.x     Document Type: Article

References (10)

1. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context
2. Thresholds for taking antihypertensive drugs in different professional and lay groups: Questionnaire survey
3. Factors affecting the acceptance of drug therapy to prevent myocardial infarction
4. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: Principle results of the Hypertension Optimal Treatment (HOT) randomised trial
5. Why has the primary prevention of myocardial infarction in the treatment of hypertension been so elusive?
6. Contribution of job control and other risk factors to social variations in coronary heart disease incidence
7. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)
8. Communicating the benefits of chronic preventive therapy: Does the format of efficacy data determine patients' acceptance of treatment?
9. The management of hypertension in the elderly by general practitioners in Merseyside: The rule of halves revisited
10. Patient preferences for medical decision making: Who really wants to participate?